Filament Health to Webcast Live at VirtualInvestorConference

VANCOUVER, British Columbia, April 25, 2022 -- Filament Health , a clinical-stage natural psychedelic drug development company, today announced that Benjamin Lightburn, CEO and Co-Founder,... | April 25, 2022

Related Keywords

United States , United Kingdom , Vancouver , British Columbia , Canada , British , Tim Regan , Adam Holdsworth , Benjamin Lightburn , Johnm Viglotti , Corporate Services , Instagram , Linkedin , Psyence Group , Twitter , Drug Administration , Journey Centers , Filament Health , Trademark Office , Strategic Communications , Division Of Psychiatry , Globenewswire Inc , United States Patent , United States Food , Cybin Therapeutics , Virtual Investor Conferences , Investor Conferences , Virtual Investor , Filament Health Corp Stock Exchange , News , Information , Press Release , Pril , 022 , Filament , Health , Natural , Sychedelic , Drug , Development , Oday , Benjamin , Ceo , Nd Flhlf Ca31685w1068 ,